Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment.

But when we analyzed the treatment duration, we observed that patients who had been treated for a longer time showed a lower percentage of LINE-1 methylation, although the correlation did not reach statistical significance (Spearman’s Rho = −0.329; p = 0.050) (Fig. 2A ).

also in 111,027 other papers